首页> 外国专利> METHOD FOR PREDICTION OF GLYCOSYLATED HAEMOGLOBIN IN PATIENTS SUFFERING FROM DIABETES MELLITUS TYPE 2

METHOD FOR PREDICTION OF GLYCOSYLATED HAEMOGLOBIN IN PATIENTS SUFFERING FROM DIABETES MELLITUS TYPE 2

机译:预测2型糖尿病患者糖基化血红蛋白的方法

摘要

FIELD: medicine.;SUBSTANCE: after DNA is recovered from peripheral venous blood, a polymorphic version +36A/G of a tumour necrosis factor receptor 1 (TNFR1) gene is analysed. If the genotype +36AA TNFR1 is found, a high level of glycosylated haemoglobin is predicted in the patients suffering from type 2 diabetes mellitus.;EFFECT: invention makes it possible to compensate type 2 diabetes mellitus in Russian individuals suffering from type 2 diabetes mellitus by TNFR1 genotyping.;2 dwg, 1 tbl, 1 ex
机译:领域:药物;目的:从外周静脉血中回收DNA后,分析肿瘤坏死因子受体1(TNFR1)基因的多态性+ 36A / G。如果发现基因型+ 36AA TNFR1,则预示患有2型糖尿病的患者体内糖基化血红蛋白水平较高。效果:本发明可以通过以下方式补偿患有2型糖尿病的俄罗斯个体的2型糖尿病: TNFR1基因分型; 2 dwg,1 tbl,1 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号